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care facility vitamin A supplementation programme, or what 
the cost of any such efforts might be. Use of other EPI 
strategies such as mass immunisation campaigns, need 
investigation as vehicles for getting vitamin A out to the 'hard-
to-reach' population. It is likely, however, that an outreach 
programme would substantially increase the overall costs of 
the vitamin A supplementation programme. Whether or not 
these additional costs would be regarded as worthwhile in 
terms of the morbidity and mortality they might be expected to 
avert, is an important albeit independent policy issue. 
We wish to acknowledge the contributions of Maude de Hoop 
(Nutrition Directorate, DOH), Lynore Dunnett (Western Cape 
nutrition subdirectorate), Leana Olivier (Western Cape MCWH 
subdirectorate), Marius le Raux and Gloria McCrae (Health 
Promotion subdirectorate, Western Cape), Peter Burgers 
(pharmaceutical services) and Tma Sanghvi (BASICS) for technical 
input. We would also like to acknowledge the financial assistance 
of the United States Agency for International Development (USA 
10) in preparing an earlier version of this work. 
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LATEX ALLERGY AT GROOTE 
SCHUUR HOSPITAL-
PREVALENCE, CLINICAL FEATURES 
AND OUTCOME 
P C Potter, I Crombie, A Marian, 0 Kosheva, B Maqula, 
M Schinkel 
Background. The incidence of latex allergy is increasing 
worldwide but there is very little information available on 
the clinical outcome for affected individuals. 
Objective. To determine the prevalence of latex allergy at 
Groote Schuur Hospital, a large teaching hospital in Cape 
Town, and to study the outcome for affected individuals. 
Method. Using a questionnaire, we screened 2 316 hospital 
workers for the presence of work-related symptoms. Workers 
who were symptomatic had Immunocap RAST (CAP RAST) 
or skin-prick tests to confirm latex sensitivity. Latex-
avoidance measures were implemented in positive subjects. 
One hundred symptomatic, sensitised individuals were 
followed up 3 months after intervention to assess their 
clinical status. A further cohort of 25 individuals with 
ongoing nasal symptoms were studied in detail. 
Results. Latex sensitisation was confirmed in 182 of 717 
symptomatic workers (25.3%). SenSitised symptomatic 
workers were significantly more likely to have had a 
previous history of urticaria (P = < 0.001), oral allergy 
syndrome (P = < 0.001), or allergic conjunctivitis (P = 0.001), 
but not hay fever, perennial rhinitis, eczema or insect 
allergies. Latex sensitisation occurred among all classes of 
health care workers. Ocular and cutaneous symptoms were 
significantly associated with positive latex sensitisation 
(P = < 0.001). After latex intervention, ocular symptoms 
(P = < 0.001), skin rashes (P = < 0.001) and wheezing 
(P = 0.001) reduced significantly. Nasal symptoms did not 
improve. Undiagnosed and untreated underlying allergies to 
common aero-allergens were present in the majority of latex-
sensitised patients with ongoing nasal symptomatology. 
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Conclusion. The prevalence of symptomatic sensitisation to 
latex allergy at Groote Schuur Hospital is between 9.2 an_9. 
11.2%. Ocular and cutaneous symptoms are the most 
prevalent in sensitised workers, and unlike nasal symptoms 
are significantly reduced when latex-avoidance measures are 
introduced. Ongoing nasal symptoms after intervention is 
instituted are probably due to other allergic sensitivities in 
latex-sensitised health care workers. 
5 Afr Med /2001; 91: 76(}.765. 
Since the first case of latex allergy was reported in the world 
literature in 1979' there has been a dramatic increase 
worldwide in the number of hospital employees developing 
latex allergy. For some workers the symptoms of allergy have 
been relatively minor, whereas other workers have been 
incapacitated by the development of severe asthma, 
rhinoconjunctivitis, generalised urticaria and even anaphylaxis, 
and have been forced to relinquish their jobs in the medical 
environment. The first case of latex allergy in South Africa was 
diagnosed in Cape Town in 1993 in a nursing sister at Groote 
Schuur Hospital. Identification of the first patient led to a pilot 
study which identified 23 further cases of latex allergy.' This 
study raised the possibility that the problem of latex allergy 
may be widespread in South Africa. 
There have been several studies reporting the prevalence of 
latex allergy in hospitals in the USA, Canada, Finland and 
Hong Kong,,.. but as yet no large surveys determining the 
prevalence of latex a llergy irl hospitals on the African contirlent 
have been published. There are also no published data 
reportirlg the outcome for those diagnosed with latex allergy 
and in whom latex avoidance measures have been instituted. 
In this paper we report on the results of a large survey of 
2 316 health professionals screened for possible latex allergy at 
Groote Schuur Hospital. 
The first phase of the study determined the prevalence of 
latex sensitisation in health care workers with allergy 
symptoms at the hospital and the profile of allergic symptoms 
in the sensitised employees. The second phase was a follow-up 
study of the first 100 employees confirmed as havirlg latex 
allergy and irl whom latex-avoidance mea ures were instituted. 
In a third phase of the study, 25 of the latex-sensitive 
employee who had presented with symptoms of nasal allergy 
in the work environment were studied further to determine to 
what extent other allergies could be contributirlg to their work-
related symptoms. 
M ETHODS 
In phase 1 of the study a standard questionnaire v1as 
administered by a trained nursing sister to 2 316 employees at 
Groote Schuur Hospital working in areas of the ho pi tal where 
latex gloves or products were used. The questionnaire sought 
information specifically relatirlg to the working location of the 
employee, pre-existirlg allergic conditions, the relationship 
between the working environment and allergic symptoms, 
specific details regarding the type of symptoms experienced in 
the work environment and the type of exposure to latex 
(rubber) products in both the work and home environments. 
Health workers who reported any allergic symptoms in the 
work en vironment were interviewed and reassessed at a 
special latex allergy clirlic established for the purposes of the 
study. 
Individuals who gave a history of clinical symptoms 
suggestive of possible latex allergy had a blood sample taken to 
determine latex-specific irnmunoglobulirl E (IgE) using the 
Immunocap (CAP RAST) test (Pharmacia, Upp ala). 
Symptomatic health workers who te ted positive(> 0.35 kU/1) 
on CAP RAST were regarded as being sensiti ed to latex. 
Symptomatic health workers who tested negative using CAP 
RAST were brought back to the clirlic for careful titrated skin-
prick testing using the Stallergenes (France) or the Alk-Abello 
(Denmark) latex skin-prick testirlg reagent . A wheal of 3 mm 
or greater than the saline-negative control was regarded a 
positive, and 2 mm was regarded a borderline. Histamirle-
positive controls were also conducted on all patients tested. 
Patient who tested positive using either skin-prick tests or 
CAP RAST were carefully instructed about appropriate latex-
avoidance measures. They were advised to wear only non-latex 
gloves (e.g. neoprene, vinyl or nitrile) and to avoid entering or 
working in any environment where powdered gloves were 
being used. They were also informed about other possible 
modes of expo ure to latex, and were provided with an 
information brochure and a booklet li ting non-latex 
alternatives in the hospital and home environments. They were 
advised to wear a medic-alert bracelet or chain and in tructed 
a to how and where to treat themselves with antihistamirles 
and/or self-injectable adrenaline hould they develop mild or 
severe symptoms from inadvertent expo ure to latex. 
The hospital management was educated regarding the risks 
of latex allergy tJ the employee, their legal responsibilities to 
the employee in relation to the South African Occupational 
Health and Safety Act (1993), the need to convert the hospital 
to a glove powder-free environment, and of their obligation to 
provide non-latex gloves to affected employee . The names of 
all affected employee were notified to the Commissioner for 
Occupational Diseases in Pretoria. 
In phase 2 of the study a follow-up questionnaire was 
administered 3- 6 months after the institution of latex-
avoidance measures, in the first 100 employees in whom latex 
allergy was confirmed by skill test or RAST. 
In this questionnaire information regardirlg the type of 
gloves used after intervention, the presence of ongoing 
---------- ----- ----
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symptoms at work and the effect of the diagnosis of latex 
allergy on the employee's ability to continue his or her work 
and on future career options was obtained. 
Because some individuals identified in phase 2 of the study 
continued to have work-related symptoms after latex-
avoidance intervention measures were instituted, a phase 3 
study was conducted. This assessed in some detail the allergic 
status of these employees in order to determine whether other 
as yet undiagnosed allergies could be accounting for their 
ongoing symptoms. Twenty-five latex-sensitive subjects who 
had ongoing nasal allergy in the work environment were 
recruited and re-interviewed using a s tandardised 
questionnaire to obtain clinical details of the duration of the 
symptoms, seasonality, medication, known allergies and 
known triggers of symptoms. Further skin-prick tests to a 
panel of eight inhalant allergens were conducted using the 
Bayer skin-prick test extracts for housedust mite, cockroach, 
dog, cat, five-grass mix, Alternaria alternata, Cladosporium 
herbarum and a tree mix, with histamine-positive and saline-
negative controls. 
Statistical analysis 
The significance of the differences in the frequency of 
parameters measured in the study groups was determined by 
the chi-square test using the Boni Ferri correction. A corrected 
P-value of < 0.05 was considered significant. 
Ethical consent 
Approval for the study was obtained from the Ethics and 
Research Committee of the University of Cape Town. 
RESULTS 
A total of 2 316 health care workers employed at Groote Schuur 
Hospital were screened. Questionnaires were returned by 1 968 
recipients (85%). Seven hundred and seventeen of the 
respondents reported work-related symptomatology. 
Sensitisation was confirmed in 182/717 subjects with 
symptoms suggesting allergy to latex (25.3%). Sensitisation was 
confirmed by CAP RAST in 39.6%, and in the remaining 60.4% 
by skin-prick tests. In 32 subjects a 'borderline' wheal, 2 mrn 
greater than the negative control, was observed in the latex 
skin-prick test. These patients also had a negative CAP RAST. 
Distribution of concurrent or previous allergic diseases in the 
health workers who were.symptomatic at work according to 
the questionnaire and who tested latex-positive are compared 
with those who tested latex-negative (Fig. 1). There were no 
significant differences in the frequency of hay-fever, perennial 
rhinitis, eczema or insect allergies in the two groups. In 
contrast, urticaria, previous anaphylaxis, oral allergy 
syndrome, allergic conjunctivitis and other occupational 
allergies were significantly more frequent in the latex-positive 










Fig. 1. Distribution of pre-existing allergic diseases in latex-positive 
(N = 182) and latex-negative (N = 535) subjects with work-related 
symptoms. Significant differences in the frequency of pre-existing 
allergic disease were present for asthma (P = 0.022), anaphylaxis 
(P = 0.007), urticaria (P = < 0.001), oral allergtj syndrome 
(P = < 0.001), allergic conjunctivitis (P = < 0.001) and other 
occupational allergies (P = < 0.001). 
group. Sensitivity to banana and avocado was significantly 
associated with positive latex sensitivity (P = < 0.001). 
Latex allergy was confirmed in individuals working in all 
areas of the hospital where powdered gloves were used. 
ursing staff working ir< theatres or labour wards had the 
highest prevalence of latex allergy, followed by doctors and 
laboratory staff. Latex-sensitive individuals were also identified 
among kitchen staff, radiographers, physiotherapists and 
cleaning staff. 
A comparison of the symptoms experienced in the work 
environment in the latex-sensitive and latex-negative groups is 
presented in Table L Ocular, chest, and cutaneous symptoms 
were significantly more common in latex-affected individuals 
(P = < 0.001). Twelve of the sensitised patients (6.6%) reported 
development of allergic symptoms when handling equipment 
other than latex gloves (e.g. rubber tubin~ anaesthetic 
apparatus, catheters and endoscopes). A further 10 of the 
sensitised patients (5.5%) reported symptoms of allergy when 
using sporting equipment or rubber equipment in the home 
environment. A few patients volunteered that they developed 
allergic reactions to condoms. 
Table I. Percentage of symptoms in the work environment 
Latex-positive Latex-negative 
group ( = 182) group (N = 535) P-value 
Itchy eyes 66.5 43.2 < 0.001 
Runny or blocked nose 59.3 49.7 5 
Coughing 28.6 19.1 5 
Wheezing 29.1 12.3 < 0.001 
Itchy skin 61.0 48.2 0.018 
Skin rashes 57.7 38.5 < 0.001 
Dizziness 12.6 9.5 5 
NS = not significant. 
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One hundred employees in whom latex allergy was 
confirmed and who continued to work at the hospital, 
participated in the 3-month follow-up study to assess the 
effectiveness of the latex-avoidance intervention strategy. This 
group included 64 nurses, 10 doctors, 8 technologists, 7 
paramedics, 2 administrative assistants, 6 cleaners and 3 other 
staff members. In this cohort 91 subjects no longer wore latex 
gloves, and 49 of the 100 em ployees experienced a clear 
reduction of symptoms once latex intervention was instituted. 
In 34, symptoms had subsided completely. In 7 individuals 
there had b een no improvement of their work-related 
symptoms. A comparison of the presence of symptoms before 
and after latex intervention is given in Fig. 2. There was a 
significant reduction in both cutaneous (P = < 0.001) and ocular 
symptoms (P = < 0.001). Although nasal and respiratory 
symptoms reduced after intervention, the reduction was not 
statistically significant. Thirty employees considered that the 
diagnosis of latex allergy had adversely affected their ability to 
continue working in their chosen career at Groote Schuur 
Hospital and 40 employees felt "that the diagnosis of la tex 
allergy would limit their career options in the future. Thirty-
two employees were considering applying to the 
Commissioner of Occupational Diseases for workers' 
compensation. Overall, 85% were satisfied that their work-
related symptoms had been adequately addressed in the work 
environment. An unexpected finding of this study was tha t 
nasal and respiratory symptoms were not improved 
significantly by latex-avoidance strategies (Fig. 2). 
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Fig. 2. Presence of symptoms before and aft~r latex avoidance 
measures were instituted in 100 workers wzth confirmed latex 
sensitisation. A significant reduction in itchy eyes (P = < 0.001), 
ztchy skin (P = < 0.001) and skin rashes (P = < 0.001) was observed. 
o significant reduction was found in incidence of rztnny or blocked 
nose, coughing, or dizziness at work. 
In the phase 3 further evaluation of 25 latex-sensitised 
employees with rhinoconjunctivitis, 7/ 25 reported having had 
nasal allergies before commencing work in the hospital. Fifteen 
of 25 had developed symptoms during the past 10 years, 12/ 25 
had perennial allergic disease, 13/ 25 reported seasonal 
exacerbations in the spring or summer, and 22/ 25 experienced 
nasal or ocular symptoms when wearing latex gloves or 
handling other latex products. 
In this cohort only 10/ 25 subjects had significan t or complete 
resolution of their symptoms since latex intervention was 
instituted. In 11 / 25 improvement was noted as being slight and 
in 4/ 25 there had been no improvement in nasal symptoms. 
Only 7/25 had previously had allergy tests. There were 13 
reports of oral allergy to fruits which cross-react with latex: 4 to 
banana, 3 to avocado, 3 to tomato and 1 each to kiwi fruit and 
apricot. Fifteen of 25 subjects believed they had pollen 
allergies, 9/ 25 pet allergies and 11/25 housedust mite allergies. 
The majority of the subjects reported tha t their symptoms were 
aggrava ted by factors such is air conditioning (20/ 25), 
perfumes (17 / 25) and sprays and paint (17 / 25). The results of 
the skin-prick tests on these 25 subjects are shown in Table ll. 
Table ll. Profile of positive specific aero-allergen sen sitivity in 25 
latex-sensitive indjviduals with rhinoconj unctivitis 
Subjects ( = 25) 




Five-gra s mix 16 
Alternaria a/temata 9 
Cladosporium herbarum 8 
Tree mix 9 
D ISCUSSION 
In this large survey of the prevalence of latex allergy at Groote 
Schuur Hospital, 1 2 (25.3%) of the taff who reported work-
related allergy symptoms suggestive of po sible latex allergy 
had a diagnosis of latex allergy confirmed by pecific t ting. 
This represents a 9.2% prevalence of confirmed latex allergy. If 
one also includes the 3 staff member who had strong clinical· 
hi tories, but with borderline test results, the prevalence of 
latex allergy rurong health care worker at Groote Schuur 
Hospital i closer to 11.2%. 
Latex allergy has been reported to be increa ing worldwide, 
with the highest prevalence being reported from hospitals in 
highly developed countries such as Finland where the 
prevalence of latex sensitisation among operating room s taff 
was found to be 7%,' and in France' and Canada' where the 
prevalence of latex sensitisation among operating room nurses, 
surgeons, anaesthe iologists and radiologi ts was between 9% 
and 10%. The present survey of 2 316 workers at Groote Schuur 
Hospital is one of the largest published in the literature to date. 
The second largest survey, a recently published cross-sectional 
survey of 1 351 hospital workers from Hamilton Hospital, 
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·Ontario, Canada, reported a 1?.1% prevalence of latex 
sensitisation (9.5% of all those eligible).• 
In South Africa two smaller studies of the prevalence of latex 
allergy have been conducted among health care workers 
working in high latex exposure areas. In a study done at Red 
Cross War Memorial Children's Hospital in Cape Town/ 7.0% 
of symptomatic workers were sensitised, and at Tygerberg 
Hospital, also in the Cape, 16.8% of a high-risk group were 
found to be sensitised to latex. A small study of latex allergy 
among 146 laboratory workers at the South African Institute for 
Medical Research (SAIMR) in Johannesburg by Stewart et aU 
using the CAP RAST test found an overall prevalence of 2.7%. 
In the latter study skin-prick tests were not conducted. The 
prevalence of latex allergy in the general population is thought 
to be less than 1%.3 
Our study at Groote Schuur Hospital only evaluated latex 
sensitisation in health care workers who were syrnptpmatic at 
work. The rate of asymptomatic sensitisation to latex in the 
hospital is probably much higher. In the study by Liss eta/.,' 
40% of the participants with positive prick tests were 
asymptomatic. In their study the rate of sensitisation increased 
with increasing glove usage. 
Confirmation of latex allergy sensitisation can be done using 
in vitro tests, e.g. the CAP RAST or by skin-prick test. We have 
. previously shown that the CAP RAST has an overall sensitivity 
of about 60% but that this is much higher for non-cutaneous 
latex allergy.' The most sensitive test for sensitisation is the 
skin-prick test. 
We have found that for individuals who give only a history 
of cutaneous symptoms, e.g. urticaria, following latex 
exposure, the skin-prick test can be safely performed as an 
initial screening test. In these patients it is much more sensitive 
than the CAP RAST.' In patients who give a clinical history of 
systemic reactions to latex (e.g. asthma or anaphylaxis) it is 
safer to do a blood test. 
More than 70% of the employees who were sensitised to 
latex reported other pre-existing atopic diseases (Fig. 1). 
Although the nursing staff comprised the largest group, other 
health care workers were at risk throughout the hospital, 
particularly among laboratory workers and doctors, but also 
among radiographers, cleaners, kitchen staff and even 
administrative staff working in areas where powdered glove 
usage was high. There was no difference in the prevalence of 
hay fever or allergic rhinitis in the latex-negative and latex-
positive groups. Ocular symptoms (P = < 0.001), wheezing 
(P = < 0.001) and cutaneous symptoms (P = < 0.001) were more 
common work-related symptoms in the latex-sensitised group 
(Table n, but nasal symptoms were not different in the two 
groups. Concurrent and cross-reacting allergies to fruits were 
also encountered, as has been reported by others.10 
Latex allergens are airborne allergens in work environments 
where powdered gloves are regularly used, and as such 
September 2001, Vol. 91, o. 9 SAM] 
represent a particular health hazard to ·health care workers who 
are inadvertently exposed to them on an almost continuous 
basis. Health care workers with an atopic diathesis have a high 
risk of eventually becoming sensitised with time, if exposed. 
Once sensitised, further exposure leads to the development of 
worsening symptoms which may be incapacitating, even life-
threatening. 
Intervention caused an overall reduction in symptoms (either 
complete or partial) in 83 of the workers. Symptoms that 
improved significantly included itchy eyes, skin rashes, and 
skin itchiness (P = < 0.001). Reasons for persistence of 
symptoms included incomplete avoidance of latex glove 
powder exposure and the presence of other underlying 
allergies which were also contributing to symptoms during 
working hours. There was no significant reduction in the 
presence of nasal symptoms overall. 
We were particularly interested to follow up our observation 
that rhinitis symptoms tended to persist even after instituting 
latex avoidance. All the workers who had ongoing symptoms 
had underlying allergies to indoor and outdoor allergens and 
in 12 subjects symptoms were perennial. It is therefore 
extremely important to investigate these patients for additional 
allergies in order to institute appropriate environmental control 
in the home, allergen avoidance and possibly allergen 
immunotherapy for a long enough period, before attributing all 
work-related symptoms to latex. 
The sudden emergence of latex allergy during the past 5 
years could be due to the fact that in state hospitals cheaper 
powdered gloves with high levels of proteins have been widely 
purchased, and gloves have been used more frequently by all 
health care workers because of the surge in infectious diseases 
such as AIDS and hepatitis B. It is probable that latex allergy is 
prevalent in all our hospitals and that this will be confirmed 
when health workers are screened in other areas. 
In terms of the South African Health and Safety Act ( o. 85 
of 1993), the employer is obliged to provide a safe environment 
for workers. 
The most effective way to manage affected individuals and 
to prevent further sensitisation is to adopt a powder-free policy 
for all hospitals in South Africa, as has been recommended in 
the UK, Canada and Scandinavia. The Food and Drug 
Administration (FDA) in the USA has ruled that all medical 
devices containing latex must now be labelled 'Caution: This 
product contains natural rubber latex which may cause allergic 
reactions' . The American Academy of Allergy, Asthma and 
Clinical Immunology has also recommended that only powder-
free latex gloves with low allergen content sh ould be 
purchased and used and that the routine use of latex gloves by 
food handlers, housekeeping, transport and medical personnel 
in low-risk situations (food handling, bed transport, physical 
examination) should be discouraged. 
The FDA has also banned the use of the term 'hypo-
I 
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allergenic glove', since such gloves still contain la tex and may 
not be used by latex-sensitised individuals, and will not 
prevent the developmen t of latex allergies in _those as yeL 
unaffected workers. 
It is essen tial that the problem of latex allergy in hospi tals 
should be addressed as a matter of urgency by the authorities 
and hospital administration in order to contair. the problem. 
Although the provision of a c0mpletely powder-free 
environment may be initially more expensive, the long-term 
savings in terms of loss of staff, morbidity, loss of productivity, 
and litigation far outweigh the short-term gains of purchasing 
cheap quality powdered gloves. 
Professor eil White performed occupational assessments on 
several of the patients. The authors acknowledge the financial 
support of Regent Medical (UK) and Laboratory Specialities (South 
Africa), and permission from the Medical Superintendent of Groote 
Schuur Hospital to publish this report. 
Dr M Isaacs of the Groote Schuur Hospital Biostatistics 
Department performed the statistical analysis of the data. 
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HIGH-DOSE IMMUNOSUPPR ES-
SIVE THERAPY IN GENERALISED 
MYASTHENIA GRAVIS- A 2-YEAR 
FOLLOW-UP STUDY 
J M Heckmann, E B LeePan, R W Eastman 
Background. Immunosuppressive (IS) therapy is increasingly 
advocated in the treatment of myasthenia gra vis (MG). This 
study assessed whether early 'high-dose' IS therapy in new 
patients with generalised MG (GMG) altered the outcome 
and reduced the morbidity of GMG. 
M ethods. Patients with GMG were treated with 'high-dose' 
IS therapy (prednisone S 1 mg/ kg, azathioprine 2- 3 
mg/ kg) and followed up for 2 years. Prednisone and 
azathioprine were ini tiated on diagnosis. Outcome 
measures were compared with those of controls previously 
treated at our clinic wi th ' low-dose' IS therapy. The primary 
outcome measure was the number of patients in remission 
at 1 and 2 years. Secondar y outcomes included the MG 
scores (MGS) after 1 and 2 years, as well as the number of 
plasma exchanges (P / E), hosp ital and intensive care unit 
(ICU) admi sions required for decompensated MG. 
Findings. At 1 and 2 years there were ignificant 
improvements in the MGS of patients treated with 'high-
dose' IS therapy compared wi th those of controls; 50% of 
these patients were in remission after 2 year comp ared 
wi th less than 16% of controls. The number of hospital and 
ICU admissions had also dropped significantly in the .fi rst 
year of patients receiving 'high-do e' IS treatment. 
Conclusion. Early 'high-dose' IS therapy using azathioprine 
and prednisone in GMG resul ted in a significant increase in 
the number of patients in remis ion and reduced morbidi ty 
at 1 and 2 years. 
5 Afr Med I 2001; 91, 765-770. 
Myasthenia gravis (MG) is an au toimmune disorder mediated 
by immunoglobulin G (IgG) antibodies to the muscle 
acetylcholine receptor (AChR).' This results in a reduction in 
the n umber of effective AChRs, impaired neuromuscular 
transmission, and therefore clinically in fatiguable muscle 
weakness.' Autoantibodies against the AChR can be detected in 
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